Literature DB >> 22817644

Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients.

Feiqian Wang1, Hongli Jiang, Kehui Shi, Yi Ren, Pan Zhang, Shaoli Cheng.   

Abstract

AIM: To investigate whether gut bacteria translocation occurs in end-stage renal disease patients and contributes to microinflammation in end-stage renal disease (ESRD).
METHODS: The subjects were divided into two groups: nondialysed ESRD patients (n = 30) and healthy controls (n = 10). Blood samples from all participants were subjected to bacterial 16S ribosomal DNA amplification and DNA pyrosequencing to determine the presence of bacteria, and the alteration of gut microbiomes were examined with the same methods. High-sensitive C-reactive protein and interleukin-6 were detected. Plasma D-lactate was tested for gut permeability.
RESULTS: Bacterial DNAs were detected in the blood of 20% (6/30) of the ESRD patients. All the observed genera in blood (Klebsiella spp, Proteus spp, Escherichia spp, Enterobacter spp, and Pseudomonas spp) were overgrown in the guts of the ESRD patients. Plasma D-lactate, High-sensitive C-reactive protein, and interleukin-6 levels were significantly higher in patients with bacterial DNA than those without. The control group showed the same results as that of patients without bacterial DNA.
CONCLUSION: Bacterial translocation occurs in ESRD patients and is associated with microinflammation in end stage renal disease.
© 2012 The Authors. Nephrology © 2012 Asian Pacific Society of Nephrology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22817644     DOI: 10.1111/j.1440-1797.2012.01647.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  67 in total

Review 1.  Hypertension as an autoimmune and inflammatory disease.

Authors:  Yalcin Solak; Baris Afsar; Nosratola D Vaziri; Gamze Aslan; Can Ege Yalcin; Adrian Covic; Mehmet Kanbay
Journal:  Hypertens Res       Date:  2016-04-07       Impact factor: 3.872

Review 2.  Impact of Dietary Fibers on Nutrient Management and Detoxification Organs: Gut, Liver, and Kidneys.

Authors:  Dorothy A Kieffer; Roy J Martin; Sean H Adams
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

Review 3.  Microbiota issue in CKD: how promising are gut-targeted approaches?

Authors:  Carmela Cosola; Maria Teresa Rocchetti; Alice Sabatino; Enrico Fiaccadori; Biagio Raffaele Di Iorio; Loreto Gesualdo
Journal:  J Nephrol       Date:  2018-08-01       Impact factor: 3.902

4.  Macrophages Are Involved in Gut Bacterial Translocation and Reversed by Lactobacillus in Experimental Uremia.

Authors:  Lingshuang Sun; Hua Liu; Hongli Jiang; Meng Wei; Shanshan Liang; Meng Wang; Kehui Shi; Quan He
Journal:  Dig Dis Sci       Date:  2015-10-30       Impact factor: 3.199

Review 5.  Metabolic Abnormalities in Diabetes and Kidney Disease: Role of Uremic Toxins.

Authors:  Laetitia Koppe; Denis Fouque; Christophe O Soulage
Journal:  Curr Diab Rep       Date:  2018-09-08       Impact factor: 4.810

6.  Gut microbial translocation in the pathogenesis of systemic inflammation in patients with end-stage renal disease.

Authors:  Nosratola D Vaziri
Journal:  Dig Dis Sci       Date:  2014-09       Impact factor: 3.199

Review 7.  The gut microbiome, diet, and links to cardiometabolic and chronic disorders.

Authors:  Judith Aron-Wisnewsky; Karine Clément
Journal:  Nat Rev Nephrol       Date:  2015-11-30       Impact factor: 28.314

8.  Measurement of the intestinal permeability in chronic kidney disease.

Authors:  Matty L Terpstra; Ramandeep Singh; Suzanne E Geerlings; Frederike J Bemelman
Journal:  World J Nephrol       Date:  2016-07-06

Review 9.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

Review 10.  Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.

Authors:  Gregory J Weber; Sathnur Pushpakumar; Suresh C Tyagi; Utpal Sen
Journal:  Pharmacol Res       Date:  2016-09-04       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.